Upadacitinib for Palmoplantar Pustulosis: An Open-label, Assessor-blinded Feasibility Study Using Historic Control Data (JAKPPPOT).
- DOI
- 10.1093/bjd/ljag410
- Published
- 2026 Sep 26
- Container
- The British journal of dermatology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/bjd/ljag410,
title = {Upadacitinib for Palmoplantar Pustulosis: An Open-label, Assessor-blinded Feasibility Study Using Historic Control Data (JAKPPPOT).},
author = {Gleeson D and Chapman S and Qin N and Gregory J and Mitchell-Gears A and Pizzato J and Powell K and Sagoo MK and Ye W and Moorhead L and Barker J and Galloway J and McAteer H and Woolf R and Pink AE and Cro S and Mahil S and Smith C},
year = {2026},
journal = {The British journal of dermatology},
doi = {10.1093/bjd/ljag410},
url = {https://doi.org/10.1093/bjd/ljag410}
}RIS
TY - JOUR TI - Upadacitinib for Palmoplantar Pustulosis: An Open-label, Assessor-blinded Feasibility Study Using Historic Control Data (JAKPPPOT). AU - Gleeson D AU - Chapman S AU - Qin N AU - Gregory J AU - Mitchell-Gears A AU - Pizzato J AU - Powell K AU - Sagoo MK AU - Ye W AU - Moorhead L AU - Barker J AU - Galloway J AU - McAteer H AU - Woolf R AU - Pink AE AU - Cro S AU - Mahil S AU - Smith C PY - 2026 JO - The British journal of dermatology DO - 10.1093/bjd/ljag410 UR - https://doi.org/10.1093/bjd/ljag410 ER -
APA
D, G., S, C., N, Q., J, G., A, M., J, P., K, P., MK, S., W, Y., L, M., J, B., J, G., H, M., R, W., AE, P., S, C., S, M., & C, S. (2026). Upadacitinib for Palmoplantar Pustulosis: An Open-label, Assessor-blinded Feasibility Study Using Historic Control Data (JAKPPPOT).. The British journal of dermatology. https://doi.org/10.1093/bjd/ljag410
Source records
- pubmed · retrieved 2026-09-26T18:41:57.003Z